We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CROs Seek FDA Guidance On Innovative Trial Design
Within the next five years, clinical research organizations foresee specific technologies redefining trial design, but also posing data integrity risks due to minimal FDA guidance.